South Asia as a Reservoir for the Global Spread of Ciprofloxacin-Resistant : A Cross-Sectional Study
Stephen Baker and colleagues use whole-genome sequencing and phylogenetic charactarization of a global collection of ciprofloxacin-resistant Shigella sonnei isolates to explore the origins of the recent spread of the antimicrobial-resistant infection.
Vyšlo v časopise:
South Asia as a Reservoir for the Global Spread of Ciprofloxacin-Resistant : A Cross-Sectional Study. PLoS Med 13(8): e32767. doi:10.1371/journal.pmed.1002055
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1002055
Souhrn
Stephen Baker and colleagues use whole-genome sequencing and phylogenetic charactarization of a global collection of ciprofloxacin-resistant Shigella sonnei isolates to explore the origins of the recent spread of the antimicrobial-resistant infection.
Zdroje
1. Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet. Elsevier Ltd; 2012;379: 2151–61.
2. Kotloff KL, Nataro JP, Blackwelder WC, Nasrin D, Farag TH, Panchalingam S, et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet. 2013;382: 209–22. doi: 10.1016/S0140-6736(13)60844-2 23680352
3. Bardhan P, Faruque ASG, Naheed A, Sack DA. Decrease in shigellosis-related deaths without Shigella spp.-specific interventions, Asia. Emerg Infect Dis. 2010/10/30 ed. 2010;16: 1718–23. doi: 10.3201/eid1611.090934 21029529
4. Vinh H, Nhu NT, Nga T V, Duy PT, Campbell JI, Hoang N V, et al. A changing picture of shigellosis in southern Vietnam: shifting species dominance, antimicrobial susceptibility and clinical presentation. BMC Infect Dis. 2009/12/17 ed. 2009;9: 204. doi: 10.1186/1471-2334-9-204 20003464
5. Thompson CN, Duy PT, Baker S. The Rising Dominance of Shigella sonnei: An Intercontinental Shift in the Etiology of Bacillary Dysentery. PLoS Negl Trop Dis. 2015;9: 1–13.
6. Bennish ML. Potentially lethal complications of shigellosis. Rev Infect Dis. 1991;13 Suppl 4: S319–S324. 2047657
7. Vinh H, Main J, Chinh M, Tam C, Trang P, Nga D, et al. Treatment of bacillary dysentery in Vietnamese children: two doses of ofloxacin versus 5-days nalidixic acid. Trans R Soc Trop Med Hyg. 2000;94: 323–326. 10975012
8. WHO. Guidelines for the control of shigellosis, including epidemics due to Shigella dysenteriae type 1. World Health Organization. 2005.
9. Ruiz J. Mechanisms of resistance to quinolones: Target alterations, decreased accumulation and DNA gyrase protection. J Antimicrob Chemother. 2003;51: 1109–1117. 12697644
10. Holt KE, Vu T, Nga T, Pham D, Vinh H, Wook D, et al. Tracking the establishment of local endemic populations of an emergent enteric pathogen. PNAS. 2013;110.
11. Horiuchi S, Inagaki Y, Yamamoto N, Okamura N, Imagawa Y, Nakaya R. Reduced susceptibilities of Shigella sonnei strains isolated from patients with dysentery to fluoroquinolones. Antimicrob Agents Chemother. 1993;37: 2486–2489. 8285640
12. Nandy S, Dutta S, Ghosh S, Ganai A, Rajahamsan J, Theodore RBJ, et al. Foodborneassociated Shigella sonnei, India, 2009 and 2010. Emerg Infect Dis. 2011;17: 2072–2073. 8 doi: 10.3201/eid1711.110403 22099103
13. Ud-Din AIMS, Wahid SUH, Latif H a, Shahnaij M, Akter M, Azmi IJ, et al. Changing trends in the prevalence of Shigella species: emergence of multi-drug resistant Shigella sonnei biotype g in Bangladesh. PLoS ONE. 2013;8: e82601. doi: 10.1371/journal.pone.0082601 24367527
14. Ruekit S, Wangchuk S, Dorji T, Tshering KP, Pootong P, Nobthai P, et al. Molecular characterization and PCR-based replicon typing of multidrug resistant Shigella sonnei isolates from an outbreak in Thimphu, Bhutan. BMC Res Notes. BMC Research Notes; 2014;7: 1–9.
15. De Lappe N, Connor JO, Garvey P, Mckeown P, Cormican M. Ciprofloxacin-Resistant Shigella sonnei Associated with Travel to India. Emerg Infect Dis. 2015;21: 2013–2015.
16. Bowen A, Hurd J, Hoover C, Khachadourian Y, Traphagen E, Harvey E, et al. Importation and Domestic Transmission of Shigella sonnei Resistant to Ciprofloxacin—United States, May 2014-February 2015. Morb Mortal Wkly Rep. 2015;64: 318–320.
17. Kim JS, Kim JJ, Kim SJ, Jeon S, Seo KY, Choi J, et al. Shigella sonnei Associated with Travel to Vietnam, Republic of Korea. Emerg Infect Dis. 2015;21: 1247–1250. doi: 10.3201/eid2107.150363 26079171
18. He M, Miyajima F, Roberts P, Ellison L, Pickard DJ, Martin MJ, et al. Emergence and global spread of epidemic healthcare-associated Clostridium difficile. Nat Genet.; 2013;45: 109–13. doi: 10.1038/ng.2478 23222960
19. Wong VK, Baker S, Pickard DJ, Parkhill J, Page AJ, Feasey N a, et al. Phylogeographical analysis of the dominant multidrug-resistant H58 clade of Salmonella Typhi identifies inter- and intracontinental transmission events. Nat Genet. 2015;
20. Holt KE, Baker S, Weill FX, Holmes EC, Kitchen A, Yu J, et al. Shigella sonnei genome sequencing and phylogenetic analysis indicate recent global dissemination from Europe. Nat Genet. 2012/08/07 ed. 2012;44: 1056–1059. doi: 10.1038/ng.2369 22863732
21. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009;25: 2078–9. doi: 10.1093/bioinformatics/btp352 19505943
22. Zerbino DR, Birney E. Velvet: algorithms for de novo short read assembly using de Bruijn graphs. Genome Res. 2008;18: 821–9. doi: 10.1101/gr.074492.107 18349386
23. Zankari E, Hasman H, Cosentino S, Vestergaard M, Rasmussen S, Lund O, et al. Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother. 2012;67: 2640–4. doi: 10.1093/jac/dks261 22782487
24. Van Boeckel TP, Gandra S, Ashok A, Caudron Q, Grenfell BT, Levin S a., et al. Global antibiotic consumption 2000 to 2010: An analysis of national pharmaceutical sales data. Lancet Infect Dis. Elsevier Ltd; 2014;14: 742–750.
25. Fahad BM, Matin A, Shill MC, Asish KD. Antibiotic usage at a primary health care unit in Bangladesh. Australas Med J. 2010;3: 414–421.
26. Kotwani A, Chaudhury RR, Holloway K. Antibiotic-prescribing practice of primary care prescribers for acute diarrhea in New Delhi, India. Value Heal. 2012;15: S16–S119.
27. Pazhani GP, Niyogi SK, Singh AK, Sen B, Taneja N, Kundu M, et al. Molecular characterization of multidrug-resistant Shigella species isolated from epidemic and endemic cases of shigellosis in India. J Med Microbiol. 2008;57: 856–863. d doi: 10.1099/jmm.0.2008/000521-0 18566144
28. Ghosh S, Pazhani GP, Chowdhury G, Guin S, Dutta S, Rajendran K, et al. Genetic characteristics and changing antimicrobial resistance among Shigella spp. isolated from hospitalized diarrhoeal patients in Kolkata, India. J Med Microbiol. 2011;60: 1460–1466. 0 doi: 10.1099/jmm.0.032920-0 21659504
29. Talukder K a., Islam Z, Dutta DK, Aminul Islam M, Khajanchi BK, Azmi IJ, et al. Antibiotic resistance and genetic diversity of Shigella sonnei isolated from patients with diarrhoea between 1999 and 2003 in Bangladesh. J Med Microbiol. 2006;55: 1257–1263. 16914657
30. Gaudreau C, Ratnayake R, Pilon P a, Gagnon S, Roger M, Lévesque S. CiprofloxacinResistant Shigella sonnei among Men Who Have Sex with Men, Canada, 2010. Emerg Infect Dis. 2011;17: 1747–1750. doi: 10.3201/eid1709.102034 21888811
31. Vrints M, Mairiaux E, Van Meervenne E, Collard JM, Bertrand S. Surveillance of antibiotic susceptibility patterns among Shigella sonnei strains isolated in Belgium during the 18-year period 1990 to 2007. J Clin Microbiol. 2009;47: 1379–1385. doi: 10.1128/JCM.02460-08 19321731
32. Uchimura M, Kishida K, Koiwai K. Increasing Incidence and the Mechanism of Resistance of Nalidixic Acid Resistant Shigella sonnei. Kansenshogaku Zasshi. 2001;75: 923–930. 11766375
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2016 Číslo 8
- Statiny indukovaná myopatie: Jak na diferenciální diagnostiku?
- MUDr. Dana Vondráčková: Hepatopatie sú pri liečbe metamizolom väčším strašiakom ako agranulocytóza
- Vztah mezi statiny a rizikem vzniku nádorových onemocnění − metaanalýza
- Nech brouka žít… Ať žije astma!
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
Najčítanejšie v tomto čísle
- Glycemic Control and the Risk of Tuberculosis: A Cohort Study
- Transitioning to Country Ownership of HIV Programs in Rwanda
- Dementia across the Lifespan and around the Globe—Pathophysiology, Prevention, Treatment, and Societal Impact: A Call for Papers
- Social Dancing and Incidence of Falls in Older Adults: A Cluster Randomised Controlled Trial